Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Challenges in migraine management

Uwe Reuter • 22 May 2020
EAN 2020
Headache Antibodies Erenumab Rimegepant Topiramate Ubrogepant

Uwe Reuter, MD, PhD, MBA, Charité – University Medicine Berlin, Berlin, Germany, talks on the the biggest challenges remaining in the migraine field. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Uwe Reuter

1:13
Discontinuation and reinitiation of migraine treatment with GCRP mAbs
Uwe Reuter • 25 Jun 2022
1:18
REGAIN trial of galcanezumab in chronic migraine
Uwe Reuter • 25 Jun 2022
1:51
Unmet needs in migraine: addressing inter-ictal burden
Uwe Reuter • 25 Jun 2022
3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter • 22 May 2020

Related Videos

3:35
Promising targets in headache research: PACAP
Alan Rapoport • 22 Mar 2024
2:03
What follow-up care is needed for patients with medication overuse headache?
Alan Rapoport • 22 Mar 2024
2:59
Medication overuse headache: current strategies and unmet needs
Morris Levin • 22 Mar 2024
1:26
The potential applications of AI in headache medicine
Morris Levin • 22 Mar 2024
The content of VJNeurology is intended for healthcare professionals